These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 16606824)

  • 1. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
    Farokhzad OC; Cheng J; Teply BA; Sherifi I; Jon S; Kantoff PW; Richie JP; Langer R
    Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6315-20. PubMed ID: 16606824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-modified PLGA nanoparticle delivery of triplex forming oligonucleotide for targeted prostate cancer therapy.
    Jiao J; Zou Q; Zou MH; Guo RM; Zhu S; Zhang Y
    Neoplasma; 2016; 63(4):569-75. PubMed ID: 27268920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J; Teply BA; Sherifi I; Sung J; Luther G; Gu FX; Levy-Nissenbaum E; Radovic-Moreno AF; Langer R; Farokhzad OC
    Biomaterials; 2007 Feb; 28(5):869-76. PubMed ID: 17055572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells.
    Farokhzad OC; Jon S; Khademhosseini A; Tran TN; Lavan DA; Langer R
    Cancer Res; 2004 Nov; 64(21):7668-72. PubMed ID: 15520166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy.
    Kolishetti N; Dhar S; Valencia PM; Lin LQ; Karnik R; Lippard SJ; Langer R; Farokhzad OC
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):17939-44. PubMed ID: 20921363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer.
    Alibolandi M; Ramezani M; Abnous K; Sadeghi F; Atyabi F; Asouri M; Ahmadi AA; Hadizadeh F
    J Control Release; 2015 Jul; 209():88-100. PubMed ID: 25912964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy.
    Werner ME; Copp JA; Karve S; Cummings ND; Sukumar R; Li C; Napier ME; Chen RC; Cox AD; Wang AZ
    ACS Nano; 2011 Nov; 5(11):8990-8. PubMed ID: 22011071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation/preparation of functionalized nanoparticles for in vivo targeted drug delivery.
    Gu F; Langer R; Farokhzad OC
    Methods Mol Biol; 2009; 544():589-98. PubMed ID: 19488725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo.
    Dhar S; Kolishetti N; Lippard SJ; Farokhzad OC
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1850-5. PubMed ID: 21233423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE
    J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel.
    Saniee F; Shabani Ravari N; Goodarzi N; Amini M; Atyabi F; Saeedian Moghadam E; Dinarvand R
    Pharm Dev Technol; 2021 Apr; 26(4):381-389. PubMed ID: 33538232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSMA targeted docetaxel-loaded superparamagnetic iron oxide nanoparticles for prostate cancer.
    Nagesh PKB; Johnson NR; Boya VKN; Chowdhury P; Othman SF; Khalilzad-Sharghi V; Hafeez BB; Ganju A; Khan S; Behrman SW; Zafar N; Chauhan SC; Jaggi M; Yallapu MM
    Colloids Surf B Biointerfaces; 2016 Aug; 144():8-20. PubMed ID: 27058278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric nanoparticles for drug delivery.
    Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
    Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plumbagin-loaded aptamer-targeted poly D,L-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy.
    Pan M; Li W; Yang J; Li Z; Zhao J; Xiao Y; Xing Y; Zhang X; Ju W
    Medicine (Baltimore); 2017 Jul; 96(30):e7405. PubMed ID: 28746182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 20. Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy.
    Wu X; Ding B; Gao J; Wang H; Fan W; Wang X; Zhang W; Wang X; Ye L; Zhang M; Ding X; Liu J; Zhu Q; Gao S
    Int J Nanomedicine; 2011; 6():1747-56. PubMed ID: 21980237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.